Package 61314-517-36

Brand: hyrimoz

Generic: adalimumab-adaz
NDC Package

Package Facts

Identity

Package NDC 61314-517-36
Digits Only 6131451736
Product NDC 61314-517
Description

3 KIT in 1 CARTON (61314-517-36) / 1 KIT in 1 KIT * 1 SYRINGE in 1 CARTON / .8 mL in 1 SYRINGE * 2 SYRINGE in 1 CARTON / .4 mL in 1 SYRINGE

Marketing

Marketing Status
Marketed Since 2023-07-01
Brand hyrimoz
Generic adalimumab-adaz
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"spl_id": "af358c91-4472-4fb1-87ba-001d67f2b4f8", "openfda": {"nui": ["N0000175610", "N0000175451", "M0001357"], "unii": ["FYS6T7F842"], "rxcui": ["2641644", "2641650", "2641653", "2641654", "2641655", "2641658", "2641660", "2641661", "2641662", "2641663", "2641664", "2641665", "2641666", "2641667", "2641668", "2641669", "2641670", "2641671", "2641672", "2641673"], "spl_set_id": ["1ac7d061-3380-468c-b077-c05f8dfbc829"], "pharm_class_cs": ["Antibodies, Monoclonal [CS]"], "pharm_class_epc": ["Tumor Necrosis Factor Blocker [EPC]"], "pharm_class_moa": ["Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "manufacturer_name": ["Sandoz Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 KIT in 1 CARTON (61314-517-36)  / 1 KIT in 1 KIT *  1 SYRINGE in 1 CARTON / .8 mL in 1 SYRINGE *  2 SYRINGE in 1 CARTON / .4 mL in 1 SYRINGE", "package_ndc": "61314-517-36", "marketing_start_date": "20230701"}], "brand_name": "HYRIMOZ", "product_id": "61314-517_af358c91-4472-4fb1-87ba-001d67f2b4f8", "dosage_form": "KIT", "product_ndc": "61314-517", "generic_name": "adalimumab-adaz", "labeler_name": "Sandoz Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "HYRIMOZ", "application_number": "BLA761071", "marketing_category": "BLA", "marketing_start_date": "20230701", "listing_expiration_date": "20271231"}